PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Sheffield, Broomhall, Sheffield, United Kingdom.\', \'Academic section of vascular surgery, department of surgery and cancer, Imperial College London, London, United Kingdom.\', \'Unit Cancer Epidemiology-Belgian Cancer Centre, Sciensano, Belgium.\', \'Leeds Institute for Medical Research, University of Leeds, Leeds, United Kingdom.\', \'Department of Plastic and Reconstructive Surgery, Leeds Teaching Hospitals, Leeds, United Kingdom.\', \'Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.\', \'MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.\', \'Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.\', \'Department of Histopathology, Leeds Teaching Hospitals, Leeds, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0234765
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 32574165
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all